Cytosorbents Crp Stock Price Patterns
| CTSO Stock | USD 0.63 0.03 4.55% |
Momentum 49
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (0.05) | EPS Estimate Current Year (0.17) | EPS Estimate Next Year (0.14) | Wall Street Target Price 5.25 | EPS Estimate Current Quarter (0.05) |
Using Cytosorbents Crp hype-based prediction, you can estimate the value of Cytosorbents Crp from the perspective of Cytosorbents Crp response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Cytosorbents Crp using Cytosorbents Crp's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Cytosorbents using crowd psychology based on the activity and movement of Cytosorbents Crp's stock price.
Cytosorbents Crp Implied Volatility | 0.51 |
Cytosorbents Crp's implied volatility exposes the market's sentiment of Cytosorbents Crp stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Cytosorbents Crp's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Cytosorbents Crp stock will not fluctuate a lot when Cytosorbents Crp's options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Cytosorbents Crp to buy its stock at a price that has no basis in reality. In that case, they are not buying Cytosorbents because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Cytosorbents Crp after-hype prediction price | USD 0.63 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Cytosorbents | Build AI portfolio with Cytosorbents Stock |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cytosorbents Crp's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Cytosorbents Crp After-Hype Price Density Analysis
As far as predicting the price of Cytosorbents Crp at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Cytosorbents Crp or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Cytosorbents Crp, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Cytosorbents Crp Estimiated After-Hype Price Volatility
In the context of predicting Cytosorbents Crp's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Cytosorbents Crp's historical news coverage. Cytosorbents Crp's after-hype downside and upside margins for the prediction period are 0.03 and 6.10, respectively. We have considered Cytosorbents Crp's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Cytosorbents Crp is dangerous at this time. Analysis and calculation of next after-hype price of Cytosorbents Crp is based on 3 months time horizon.
Cytosorbents Crp Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Cytosorbents Crp is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cytosorbents Crp backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Cytosorbents Crp, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.21 | 5.47 | 0.00 | 0.02 | 8 Events / Month | 7 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.63 | 0.63 | 0.00 |
|
Cytosorbents Crp Hype Timeline
Cytosorbents Crp is currently traded for 0.63. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.02. Cytosorbents is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is currently at -0.21%. %. The volatility of related hype on Cytosorbents Crp is about 6670.73%, with the expected price after the next announcement by competition of 0.61. About 16.0% of the company shares are held by company insiders. The book value of Cytosorbents Crp was currently reported as 0.14. The company recorded a loss per share of 0.18. Cytosorbents Crp had not issued any dividends in recent years. The entity had 1:25 split on the 5th of December 2014. Given the investment horizon of 90 days the next projected press release will be in about 8 days. Check out Cytosorbents Crp Basic Forecasting Models to cross-verify your projections.Cytosorbents Crp Related Hype Analysis
Having access to credible news sources related to Cytosorbents Crp's direct competition is more important than ever and may enhance your ability to predict Cytosorbents Crp's future price movements. Getting to know how Cytosorbents Crp's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Cytosorbents Crp may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ICCM | Icecure Medical | 0.01 | 9 per month | 0.00 | (0.13) | 4.35 | (5.63) | 14.09 | |
| TELA | Tela Bio | 0.01 | 10 per month | 0.00 | (0.15) | 5.38 | (8.33) | 22.82 | |
| MDAI | Spectral AI | (0.08) | 7 per month | 0.00 | (0.06) | 6.29 | (6.98) | 15.64 | |
| SRTS | Sensus Healthcare | (0.05) | 11 per month | 2.62 | 0.15 | 9.26 | (4.61) | 26.96 | |
| NMTC | Neuroone Medical Technologies | (0.06) | 13 per month | 3.78 | 0.05 | 9.59 | (6.85) | 23.46 | |
| BDMD | Baird Medical Investment | 0.01 | 8 per month | 0.00 | (0.08) | 8.67 | (8.00) | 26.61 | |
| ECOR | Electrocore LLC | (0.09) | 9 per month | 3.57 | 0.13 | 10.17 | (6.07) | 30.74 | |
| TELO | Telomir Pharmaceuticals Common | 0.04 | 5 per month | 0.00 | (0.09) | 4.58 | (4.93) | 15.74 | |
| BDSX | Biodesix | (0.24) | 9 per month | 5.17 | 0.11 | 19.87 | (9.42) | 62.04 | |
| SER | Serina Therapeutics | (0.37) | 7 per month | 0.00 | (0.15) | 8.95 | (8.66) | 23.77 |
Cytosorbents Crp Additional Predictive Modules
Most predictive techniques to examine Cytosorbents price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cytosorbents using various technical indicators. When you analyze Cytosorbents charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Cytosorbents Crp Predictive Indicators
The successful prediction of Cytosorbents Crp stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Cytosorbents Crp, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Cytosorbents Crp based on analysis of Cytosorbents Crp hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Cytosorbents Crp's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Cytosorbents Crp's related companies. | 2025 | 2026 (projected) | Dividend Yield | 0.002151 | 0.002043 | Price To Sales Ratio | 1.6 | 1.52 |
Pair Trading with Cytosorbents Crp
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cytosorbents Crp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cytosorbents Crp will appreciate offsetting losses from the drop in the long position's value.Moving against Cytosorbents Stock
| 0.48 | GKOS | Glaukos Corp | PairCorr |
| 0.45 | VPT | VentriPoint Diagnostics | PairCorr |
| 0.42 | BLCO | Bausch Lomb Corp | PairCorr |
The ability to find closely correlated positions to Cytosorbents Crp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cytosorbents Crp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cytosorbents Crp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cytosorbents Crp to buy it.
The correlation of Cytosorbents Crp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cytosorbents Crp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cytosorbents Crp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cytosorbents Crp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Cytosorbents Crp Basic Forecasting Models to cross-verify your projections. To learn how to invest in Cytosorbents Stock, please use our How to Invest in Cytosorbents Crp guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Will Health Care Equipment & Supplies sector continue expanding? Could Cytosorbents diversify its offerings? Factors like these will boost the valuation of Cytosorbents Crp. Projected growth potential of Cytosorbents fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Cytosorbents Crp data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.18) | Revenue Per Share | Quarterly Revenue Growth 0.101 | Return On Assets | Return On Equity |
Investors evaluate Cytosorbents Crp using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Cytosorbents Crp's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Cytosorbents Crp's market price to deviate significantly from intrinsic value.
It's important to distinguish between Cytosorbents Crp's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cytosorbents Crp should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Cytosorbents Crp's market price signifies the transaction level at which participants voluntarily complete trades.